Trial Profile
A Phase II Study of Bevacizumab in Combination With Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin
- Indications Cervical cancer
- Focus Adverse reactions
- 08 Jun 2010 Status changed from active, no longer recruiting to completed.
- 11 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.